{"id":"W4403086466","doi":"10.1016/j.ebiom.2024.105322","title":"Insights into the use of biomarkers in clinical trials in Alzheimer's disease","year":2024,"lang":"en","type":"review","venue":"EBioMedicine","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Instituto de Salud Carlos III; Fonds de Recherche du Québec - Santé; Horizon 2020 Framework Programme; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas; Instituto Serrapilheira; Fundación Tatiana Pérez de Guzmán el Bueno; Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul; Conselho Nacional de Desenvolvimento Científico e Tecnológico; National Institutes of Health; Generalitat de Catalunya; Instituto Nacional de Ciência e Tecnologia para Excitotoxicidade e Neuroproteção; European Regional Development Fund; European Commission; Alzheimer's Association","keywords":"Alzheimer's disease; Clinical trial; Disease; Medicine; Bioinformatics; MEDLINE; Biology; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004235723,0.0006535696,0.005414127,0.001777353,0.00003546295,0.00002982648,0.0003370954,0.0003954783,0.0001072206],"category_scores_gemma":[0.004722119,0.0003068642,0.001557972,0.002338656,0.0008566729,0.00009714151,0.0002324022,0.001038324,0.0002008305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002155763,"about_ca_system_score_gemma":0.002287523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000486426,"about_ca_topic_score_gemma":0.00008591879,"domain_scores_codex":[0.990584,0.003107761,0.004010939,0.0008615112,0.0009416442,0.0004941748],"domain_scores_gemma":[0.992586,0.004567343,0.0006693293,0.001163821,0.00009579305,0.0009177864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008497579,0.001235201,0.0009231045,0.00940915,0.03386285,0.004880271,0.0001475161,8.269193e-8,1.539821e-7,0.00006213792,0.008846951,0.9397828],"study_design_scores_gemma":[0.003555005,0.0005307428,0.001859705,0.05919937,0.03609489,0.00001730669,0.00004649867,0.00006028421,3.689748e-7,0.0002028782,0.8981426,0.0002903527],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003314336,0.9936264,0.000001352242,0.001013983,0.0005818708,0.004225843,0.00009692566,0.00003632056,0.00008588096],"genre_scores_gemma":[0.0024178,0.9954343,0.00006085312,0.0001470157,0.000545211,0.000403743,0.000859215,0.00009345013,0.00003840795],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9394925,"threshold_uncertainty_score":0.9999384,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3710072076126499,"score_gpt":0.5215455738818651,"score_spread":0.1505383662692151,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}